<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0045">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Zucha</surname>
    <given-names>MA</given-names>
   </string-name>, 
   <string-name>
    <surname>Wu</surname>
    <given-names>AT</given-names>
   </string-name>, 
   <string-name>
    <surname>Lee</surname>
    <given-names>WH</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer</article-title>. 
  <source>Oncotarget</source>
  <year>2015</year>;
  <volume>6</volume>:
  <fpage>13255</fpage>–
  <lpage>68</lpage>.
  <pub-id pub-id-type="pmid">26036311</pub-id>
 </mixed-citation>
</ref>
